Skip to Content

Hemangeol Approval History

  • FDA approved: Yes (First approved March 14th, 2014)
  • Brand name: Hemangeol
  • Generic name: propranolol hydrochloride
  • Dosage form: Oral Solution
  • Company: Pierre Fabre Dermatologie
  • Treatment for: Infantile Hemangioma

Hemangeol (propranolol hydrochloride) is a pediatric beta-blocker formulation indicated for the treatment of proliferating infantile hemangioma.

Development History and FDA Approval Process for Hemangeol

Mar 18, 2014Approval Pierre Fabre Obtains FDA Approval to Market Hemangeol for the Treatment of Infantile Hemangioma

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.